English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/114258
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Use of B7 costimulatory molecules as adjuvants in a prime-boost vaccination against Visna/Maedi ovine lentivirus

AuthorsAndrés, Ximena de ; Reina, Ramsés ; Reina, Ramsés ; Ciriza, Jesús; Crespo, Helena ; Glaria, Idoia ; Ramírez, Hugo ; Grilló, María Jesús ; Grilló, María Jesús ; Pérez, Marta M.; Andrés, Damián F. de ; Amorena Zabalza, Beatriz
KeywordsSheep
Small ruminant lentivirus
DNA vaccination
B7 costimulatory molecules
Issue Date23-Jul-2009
PublisherElsevier
CitationVaccine 27: 4591-4600 (2009)
AbstractRNA transcripts of the B7 family molecule (CD80) are diminished in blood leukocytes from animals clinically affected with Visna/Maedi virus (VMV) infection. This work investigates whether the use of B7 genes enhances immune responses and protection in immunization-challenge approaches. Sheep were primed by particle-mediated epidermal bombardment with VMV gag and env gene recombinant plasmids together with plasmids encoding both CD80 and CD86 or CD80 alone, boosted with gag and env gene recombinant modified vaccinia Ankara virus and challenged intratracheally with VMV. Immunization in the presence of one or both of the B7 genes resulted in CD4+ T cell activation and antibody production (before and after challenge, respectively), but only immunization with CD80 and CD86 genes together, and not CD80 alone, resulted in a reduced number of infected animals and increased early transient cytotoxic T lymphocytes (CTL) responses. Post-mortem analysis showed an immune activation of lymphoid tissue in challenge-target organs in those animals that had received B7 genes compared to unvaccinated animals. Thus, the inclusion of B7 genes helped to enhance early cellular responses and protection (diminished proportion of infected animals) against VMV infection. © 2009 Elsevier Ltd. All rights reserved.
Publisher version (URL)http://dx.doi.org/10.1016/j.vaccine.2009.05.080
URIhttp://hdl.handle.net/10261/114258
DOI10.1016/j.vaccine.2009.05.080
ISSN0264-410X
Appears in Collections:(IDAB) Artículos
Files in This Item:
File Description SizeFormat 
Use of B7 costimulatory molecules_Andres_.pdf450,82 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.